A Tumor-Activatable DNA Nanoengager That Orchestrates NK Receptor Clustering and Immune Checkpoint Blockage to Enhance Antitumor Cytotoxicity
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
This integrated DNA system enables synergistic integration of targeted activation, dual checkpoint blockade, and tumor microenvironment responsiveness, providing a novel smart nanoscale strategy to overcome multifaceted immune evasion in solid tumors and enhance the safety and efficacy of NK cell-based immunotherapy.
Appeared: Wednesday, October 14. Journal of the American Chemical Society. Peer-reviewed journal.
DOI: 10.1021/jacs.6c15706